术中神经电生理监测并未必然改善择期动脉瘤夹闭术的总体长期结局
该研究纳入2007—2014年择期未破裂颅内动脉瘤夹闭术患者,比较引入术中神经电生理监测(IOM)前后(NIOM组136例、IOM组138例)的神经功能结局。两组术后新发神经功能缺损数量与性质及恢复率均无显著差异。作者认为IOM对总体神经功能结局的假定正面影响未达统计学显著。
要点
- IOM组与NIOM组术后新发缺损率分别为13.0%与13.2%,永久缺损分别为5.8%与7.3%,均无显著差异。
- SSEP/MEP监测敏感性45.5%、特异性89.8%、阳性预测值27.8%、阴性预测值95.0%。
- 作者认为从医疗法律角度IOM并非所有神经血管手术都严格要求,未来研究应关注高危复杂手术患者。
核心结论
- 引入SSEP/MEP监测对择期未破裂颅内动脉瘤夹闭术总体神经功能结局的假定正面影响未达统计学显著。
- 作者认为从医疗法律角度看,IOM并非所有神经血管手术都严格要求,未来研究应仔细评估可能更明显获益的高危复杂手术患者。
研究设计与样本
- 研究纳入时间为2007—2014年,为ECUIA手术引入IOM前后对比分析。
- NIOM组为2007—2010年ECUIA手术患者136例;IOM组为2011—2014年引入IOM后的ECUIA手术患者138例。
- SSEP/MEP异常截断值设为波幅下降≥50%,SSEP/MEP变化与神经功能结局进行相关性分析。
- IOM不可检测的缺损(延髓、视觉、共济失调)未纳入风险分层。
主要发现
- IOM组年龄高于NIOM组(57岁 vs 54岁,p=0.012)。
- IOM组术后新发缺损18例(13.0%,其中永久性5.8%),包括偏身综合征9例、昏迷2例、延髓症状4例、视觉缺损3例。
- NIOM组术后新发缺损18例(13.2%,其中永久性7.3%,包括偏身综合征7例)。
- 两组术后缺损数量、性质及恢复率均无显著差异。
- IOM组SSEP与MEP在99%的病例中可用;18例出现显著变化,其中4例术后偏身综合征、1例持续昏迷状态(5例真阳性);12例无新发可检测缺损(假阳性),其中2例有无症状性梗死;5例新发偏身综合征和1例昏迷患者未显示显著SSEP/MEP改变(假阴性)。
关键数值与推荐
- SSEP/MEP异常的截断值为波幅下降≥50%。
- SSEP/MEP监测敏感性45.5%、特异性89.8%、阳性预测值27.8%、阴性预测值95.0%。
临床怎么用
- 原文结论未据此给出临床推荐。
局限性
- IOM不可检测的缺损(延髓、视觉、共济失调)未纳入风险分层。
- 作者指出未来研究应仔细评估可能更明显获益的高危复杂手术患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intraoperative neuromonitoring (IOM), particularly of somatosensory-evoked potentials (SSEPs) and motor-evoked potentials (MEPs), evolved as standard of care in a variety of neurosurgical procedures. Case series report a positive impact of IOM for elective microsurgical clipping of unruptured intracranial aneurysms (ECUIA), whereas systematic evaluation of its predictive value is lacking. Therefore, the authors analyzed the neurological outcome of patients undergoing ECUIA before and after IOM introduction to this procedure. METHODS: The dates of inclusion in the study were 2007-2014. In this period, ECUIA procedures before (n = 136, NIOM-group; 2007-2010) and after introduction of IOM (n = 138, IOM-group; 2011-2014) were included. The cutoff value for SSEP/MEP abnormality was chosen as an amplitude reduction ≥ 50%. SSEP/MEP changes were correlated with neurological outcome. IOM-undetectable deficits (bulbar, vision, ataxia) were not included in risk stratification. RESULTS: There was no significant difference in sex distribution, follow-up period, subarachnoid hemorrhage risk factors, aneurysm diameter, complexity, and location. Age was higher in the IOM-group (57 vs 54 years, p = 0.012). In the IOM group, there were 18 new postoperative deficits (13.0%, 5.8% permanent), 9 hemisyndromes, 2 comas, 4 bulbar symptoms, and 3 visual deficits. In the NIOM group there were 18 new deficits (13.2%; 7.3% permanent, including 7 hemisyndromes). The groups did not significantly differ in the number or nature of postoperative deficits, nor in their recovery rate. In the IOM group, SSEPs and MEPs were available in 99% of cases. Significant changes were noted in 18 cases, 4 of which exhibited postoperative hemisyndrome, and 1 suffered from prolonged comatose state (5 true-positive cases). Twelve patients showed no new detectable deficits (false positives), however 2 of these cases showed asymptomatic infarction. Five patients with new hemisyndrome and 1 comatose patient did not show significant SSEP/MEP alterations (false negatives). Overall sensitivity of SSEP/MEP monitoring was 45.5%, specificity 89.8%, positive predictive value 27.8%, and negative predictive value 95.0%. CONCLUSIONS: The assumed positive impact of introducing SSEP/MEP monitoring on overall neurological outcome in ECUIA did not reach significance. This study suggests that from a medicolegal point of view, IOM is not stringently required in all neurovascular procedures. However, future studies should carefully address high-risk patients with complex procedures who might benefit more clearly from IOM than others.
引用
- Greve T, Stoecklein VM, Dorn F, et al. Introduction of intraoperative neuromonitoring does not necessarily improve overall long-term outcome in elective aneurysm clipping. J Neurosurg. 2019. PMID: 30925469. doi:10.3171/2018.12.JNS182177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。